ALLI vs ALPELISIB: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
ALLI vs ALPELISIB: Safety Overview
| Metric | ALLI | ALPELISIB |
|---|---|---|
| Total FAERS Reports | 1,057 | 8,419 |
| Deaths Reported | 0 | 1,271 |
| Death Rate | N/A | 15.1% |
| Hospitalizations | 14 | 1,705 |
| Average Patient Age | 46.7 yrs | 58.8 yrs |
| % Female Patients | N/A | 94.7% |
| FDA Approval Date | N/A | Apr 24, 2024 |
| Manufacturer | N/A | Novartis Pharmaceuticals Corporation |
| Route | N/A | ORAL |
| Marketing Status | N/A | Prescription |